These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 9405275

  • 1. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA.
    Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [Abstract] [Full Text] [Related]

  • 2. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A, Petersen HH, Heegaard CW, Oka K, Christensen A, Dubin A, Chan L, Andreasen PA.
    Eur J Biochem; 1997 Sep 01; 248(2):270-81. PubMed ID: 9346278
    [Abstract] [Full Text] [Related]

  • 3. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.
    FEBS J; 2006 Nov 01; 273(22):5143-59. PubMed ID: 17042782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S, Lawrence DA, Argraves WS.
    J Biol Chem; 1996 Apr 05; 271(14):8215-20. PubMed ID: 8626514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells.
    Zhang JC, Sakthivel R, Kniss D, Graham CH, Strickland DK, McCrae KR.
    J Biol Chem; 1998 Nov 27; 273(48):32273-80. PubMed ID: 9822706
    [Abstract] [Full Text] [Related]

  • 13. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F.
    J Cell Biol; 1995 Dec 27; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [Abstract] [Full Text] [Related]

  • 14. Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.
    Casslén B, Gustavsson B, Angelin B, Gåfvels M.
    Mol Hum Reprod; 1998 Jun 27; 4(6):585-93. PubMed ID: 9665342
    [Abstract] [Full Text] [Related]

  • 15. Both pro-uPA and uPA: PAI-1 complex bind to the alpha 2-macroglobulin receptor/LDL receptor-related protein. Evidence for multiple independent contacts between the ligands and receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Gliemann J, Andreasen PA.
    Ann N Y Acad Sci; 1994 Sep 10; 737():483-5. PubMed ID: 7944152
    [No Abstract] [Full Text] [Related]

  • 16. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
    Bu G, Maksymovitch EA, Schwartz AL.
    J Biol Chem; 1993 Jun 15; 268(17):13002-9. PubMed ID: 8389767
    [Abstract] [Full Text] [Related]

  • 17. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase.
    Kounnas MZ, Henkin J, Argraves WS, Strickland DK.
    J Biol Chem; 1993 Oct 15; 268(29):21862-7. PubMed ID: 7691818
    [Abstract] [Full Text] [Related]

  • 18. The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein.
    Croucher D, Saunders DN, Ranson M.
    J Biol Chem; 2006 Apr 14; 281(15):10206-13. PubMed ID: 16459332
    [Abstract] [Full Text] [Related]

  • 19. The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.
    Gettins PG, Dolmer K.
    J Biol Chem; 2016 Jan 08; 291(2):800-12. PubMed ID: 26555266
    [Abstract] [Full Text] [Related]

  • 20. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG.
    Mol Biol Cell; 2001 May 08; 12(5):1467-79. PubMed ID: 11359936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.